Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yun-Chu Lin

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Biophysical Journal|July 2, 2021
Traction force microscopy by deep learningYu-Li Wang, Yun-Chu Lin
Blood Cell Therapy|January 30, 2023
Post-HSCT relapsed precursor B-cell ALL successfully salvaged by BiTE followed by consolidation CAR-T cell therapy: A report of two casesWei-Han Huang, Chun-Rong Tong, Tong Wu, et al.
Dental Materials : Official Publication of the Academy of Dental Materials|June 25, 2014
Examination of ceramic/enamel interfacial debonding using acoustic emission and optical coherence tomographyChun-Li Lin, Wen-Chuan Kuo, Yen-Hsiang Chang, et al.
Biochemical Pharmacology|January 22, 2022
Selective stabilization of the intermediate inactivated Na<sup>+</sup> channel by the new-generation anticonvulsant rufinamideYun-Chu Lin, Yi-Chen Lai, Tien-Hung Lin, et al.
Hematology (Amsterdam, Netherlands)|July 3, 2024
Treatment pattern among patients with relapsed/refractory multiple myeloma (RRMM) who had received pomalidomide-based regimens in TaiwanChieh-Lin Jerry Teng, Su-Peng Yeh, Tsai-Yun Chen, et al.
Annals of Neurology|March 21, 2021
How Can an Na<sup>+</sup> Channel Inhibitor Ameliorate Seizures in Lennox-Gastaut Syndrome?Yun-Chu Lin, Yi-Chen Lai, Ping Chou, et al.
Annals of Hematology|January 23, 2020
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclaxYu-Wen Wang, Cheng-Hong Tsai, Chien-Chin Lin, et al.
Blood Cancer Journal|October 13, 2020
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burdenYu-Hung Wang, Chien-Chin Lin, Sze-Hwei Lee, et al.
Hematological Oncology|January 24, 2025
Comprehensive Characterization of Overt Myelofibrosis in an Asian Cohort: Phenotype, Mutation Landscape and Discordance Among Scoring SystemsYu-Sung Chang, Yu-Hung Wang, Chao-Hung Wei, et al.
Annals of Hematology|November 12, 2021
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experienceYu-Wen Wang, Xavier Cheng-Hong Tsai, Hsin-An Hou, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Biophysical Journal|July 2, 2021
Traction force microscopy by deep learningYu-Li Wang, Yun-Chu Lin
Blood Cell Therapy|January 30, 2023
Post-HSCT relapsed precursor B-cell ALL successfully salvaged by BiTE followed by consolidation CAR-T cell therapy: A report of two casesWei-Han Huang, Chun-Rong Tong, Tong Wu, et al.
Dental Materials : Official Publication of the Academy of Dental Materials|June 25, 2014
Examination of ceramic/enamel interfacial debonding using acoustic emission and optical coherence tomographyChun-Li Lin, Wen-Chuan Kuo, Yen-Hsiang Chang, et al.
Biochemical Pharmacology|January 22, 2022
Selective stabilization of the intermediate inactivated Na<sup>+</sup> channel by the new-generation anticonvulsant rufinamideYun-Chu Lin, Yi-Chen Lai, Tien-Hung Lin, et al.
Hematology (Amsterdam, Netherlands)|July 3, 2024
Treatment pattern among patients with relapsed/refractory multiple myeloma (RRMM) who had received pomalidomide-based regimens in TaiwanChieh-Lin Jerry Teng, Su-Peng Yeh, Tsai-Yun Chen, et al.
Annals of Neurology|March 21, 2021
How Can an Na<sup>+</sup> Channel Inhibitor Ameliorate Seizures in Lennox-Gastaut Syndrome?Yun-Chu Lin, Yi-Chen Lai, Ping Chou, et al.
Annals of Hematology|January 23, 2020
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclaxYu-Wen Wang, Cheng-Hong Tsai, Chien-Chin Lin, et al.
Blood Cancer Journal|October 13, 2020
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burdenYu-Hung Wang, Chien-Chin Lin, Sze-Hwei Lee, et al.
Hematological Oncology|January 24, 2025
Comprehensive Characterization of Overt Myelofibrosis in an Asian Cohort: Phenotype, Mutation Landscape and Discordance Among Scoring SystemsYu-Sung Chang, Yu-Hung Wang, Chao-Hung Wei, et al.
Annals of Hematology|November 12, 2021
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experienceYu-Wen Wang, Xavier Cheng-Hong Tsai, Hsin-An Hou, et al.
Pageof 2